Effect of brexanolone on depressive symptoms, anxiety, and insomnia in women with postpartum depression: Pooled analyses from 3 double-blind, randomized, placebo-controlled clinical trials in the HUMMINGBIRD clinical program-Reference-Cited by-同舟云学术

Effect of brexanolone on depressive symptoms, anxiety, and insomnia in women with postpartum depression: Pooled analyses from 3 double-blind, randomized, placebo-controlled clinical trials in the HUMMINGBIRD clinical program

Published:2023-01 Issue: Volume:320 Page:353-359
ISSN:0165-0327
Container-title:Journal of Affective Disorders
language:en
Short-container-title:Journal of Affective Disorders

Author:

Epperson C. Neill,Rubinow David R.,Meltzer-Brody Samantha,Deligiannidis Kristina M.,Riesenberg Robert,Krystal Andrew D.,Bankole Kemi,Huang Ming-Yi,Li Haihong,Brown Colville,Kanes Stephen J.,Lasser Robert

Publisher

Elsevier BV

Subject

Psychiatry and Mental health,Clinical Psychology

Reference64 articles.

1. Diagnostic and Statistical Manual of Mental Disorders (DSM-5),2013

2. Vital signs: postpartum depressive symptoms and provider discussions about perinatal depression - United States, 2018;Bauman;MMWR Morb. Mortal. Wkly Rep.,2020

3. Births: final data for 2017;Martin;Natl. Vital Stat. Rep.,2018

4. Prevalence estimates of gestational diabetes mellitus in the United States, pregnancy risk assessment monitoring system (PRAMS), 2007–2010;DeSisto;Prev. Chronic Dis.,2014

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of sleep protection in preventing and treating postpartum depression;Seminars in Perinatology;2024-10

2. New treatments: Opportunities and challenges;Seminars in Perinatology;2024-10

3. Expanding the therapeutic potential of neuro(active)steroids: a promising strategy for hyperdopaminergic behavioral phenotypes;Neuroscience & Biobehavioral Reviews;2024-09

4. The Emerging Role of Neurosteroids: Novel Drugs Brexanalone, Sepranolone, Zuranolone, and Ganaxolone in Mood and Neurological Disorders;Cureus;2024-07-31

5. Neurosteroids and translocator protein 18 kDa (TSPO) ligands as novel treatment options in depression;European Archives of Psychiatry and Clinical Neuroscience;2024-07-08